Conference Agenda
Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).
|
Session Overview |
| Session | ||
Session Plénière 3: Hatice ALTUG (EPFL) - Nanophotonics: Enabling Technology for Next-Gen Biosensors, Bioimaging and Spectroscopy
| ||
| Session Abstract | ||
|
Our laboratory is developing next-generation optical and bioanalytical technologies enabled by nanophotonic sensing, imaging and spectroscopy. Our research focuses on creating label free, real-time, and high-throughput platforms for the analysis of biomolecules, pathogens and living systems with applications spanning from life science research, disease diagnostics, and point-of-care testing. We leverage an interdisciplinary approach that innovatively combines nanophotonics with microfluidics, surface chemistry and data science methods to achieve new sensing functions and high performance. In this talk, I will highlight some of our recent advances including surface-enhanced infrared absorption (SEIRA) based microarrays for drug screening and structural sensitive biomarker detection relevant to neurodegenerative diseases, multi-modal imaging platforms for live cell studies, self-illuminating biosensors based on inelastic electron tunneling. I will also cover emerging nanophotonic architectures such as gradient metasurfaces for ultra-broadband and imaging based SEIRA spectroscopy, chirality control, strong coupling, and resonantly enhanced high harmonic generation.
| ||
| Presentations | ||
NANOPHOTONICS: ENABLING TECHNOLOGY FOR NEXT-GEN BIOSENSORS, BIOIMAGING AND SPECTROSCOPY EPFL Our laboratory is developing next-generation optical and bioanalytical technologies enabled by nanophotonic sensing, imaging and spectroscopy. Our research focuses on creating label free, real-time, and high-throughput platforms for the analysis of biomolecules, pathogens and living systems with applications spanning from life science research, disease diagnostics, and point-of-care testing. | ||

